Page results
-
This page provides information about the thermoregulatory sweat test (TST).
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
-
A new trial led by UCLH and UCL is looking at whether music therapy can help patients recover from severe brain injury.
-
This provides information about a treatment for uterine fibroids known as ‘transcervical ultrasound-guided radiofrequency ablation’. You may also hear it called by the Manufacturer’s name ‘Sonata®’ for short.
-
Patient information leaflet for patients suffering form long COVID who are experiencing breathlessness or changes in their breathing pattern.
-
A summary of a twitter chat hosted by the Macmillan Support and Information Service on cancer-related fatigue with advice about to manage it.
-
This patient information includes different relaxation techniques which patients being seen by the Post-COVID Service team may find useful.
-
An evaluation of temporary changes to children and young people’s services in North Central London (NCL) in the autumn and winter of 2020/21 has been published.
-
After delivering more than 80,000 vaccines, the vaccination centre at The Francis Crick Institute closes its doors today (13 August 2021) with the last vaccination taking place at 7pm.
-
Professor Catherine Mummery is a consultant neurologist with a research interest in early phase clinical trials in dementia and those at risk of dementia.
File results
-
FOI/2023/0386 - Sickle Cell staffing and patients
-
FOI/2023/0384 - Cyber security attacks 2020-2022
-
FOI/2023/0383 - Cataract referrals
-
FOI/2023/0380 - Flexible nurse bank rates/ spend March 2023
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0082 - Organisation structure for Performance and Planning department
-
FOI/2023/0081 - Biometric technology wearables/ data collection
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia
-
FOI/2023/0083 - Software systems/ suppliers used at Trust